Open Collections

UBC Faculty Research and Publications

Direct To Consumer Advertising : Finasteride for male pattern hair loss Therapeutics Initiative (University of British Columbia)

Description

Therapeutics Letter 40 considers the impact of direct to consumer advertising (DTCA) on finasteride for male pattern hair loss. Conclusions: DTCA appears to increase drug sales and adds to the pressure on busy clinicians. Before yielding to this pressure, physicians must be able to convey to the patient in a meaningful way the known benefits, harms, and risks.

Item Metadata

Title
Direct To Consumer Advertising : Finasteride for male pattern hair loss
Alternate Title
Therapeutics Letter 40
Creator
Therapeutics Initiative (University of British Columbia)
Date Issued
2001-04
Description
Therapeutics Letter 40 considers the impact of direct to consumer advertising (DTCA) on finasteride for male pattern hair loss. Conclusions: DTCA appears to increase drug sales and adds to the pressure on busy clinicians. Before yielding to this pressure, physicians must be able to convey to the patient in a meaningful way the known benefits, harms, and risks.
Subject
Alopecia; Direct-to-Consumer Advertising; Finasteride
Genre
Other
Type
Text
Language
eng
Notes
The UBC TI is funded by the BC Ministry of Health to provide evidence-based information about drug therapy. We neither formulate nor adjudicate provincial drug policies.
Date Available
2023-06-20
Provider
Vancouver : University of British Columbia Library
Rights
Attribution-NonCommercial-NoDerivatives 4.0 International
DOI
10.14288/1.0433619
URI
http://hdl.handle.net/2429/85029
Affiliation
Medicine, Faculty of; Anesthesiology, Pharmacology and Therapeutics, Department of
Peer Review Status
Reviewed
Scholarly Level
Faculty; Researcher
Rights URI
http://creativecommons.org/licenses/by-nc-nd/4.0/
Aggregated Source Repository
DSpace

Item Media

Item Citations and Data

Rights

Attribution-NonCommercial-NoDerivatives 4.0 International